When the expressions of RUNX3 and TGF-β were restored by treatment with 5-aza-2′-deoxycytidine before inoculation into the in vivo model, the tumor size was smaller and the animal survival time was prolonged. The gene discussed is TGFB1; the disease is neoplasm.